Taken together, our studies have comprehensively analyzed the protein expression profiles of ERβ1 across multiple breast cancer sub-types and demonstrated critical roles for this receptor in mediating the effectiveness of multiple therapeutic treatment strategies for breast cancer patients that are related in part to the presence and absence of ERα expression. This evidence concerns the gene ESR1 and breast carcinoma.